Here’s what companies are saying about Ebola

The outbreak of Ebola in West Africa is forcing businesses worldwide to assess the disease’s impact on their bottom lines. From makers of drugs and diagnostic tools to the travel industry, companies are confronting opportunities and threats from Ebola, and factoring the virus into their planning.

Here’s our working list of what exactly companies have to say about Ebola, gleaned from earnings calls, news reports, social media and statements. We’ll continue to update this information as earnings season unfolds and the disease takes its course.

Seen any statements we may have missed? Tweet them to @bbrowdie.

October

“Development of the vaccine candidate is progressing at an unprecedented rate…”

- GlaxoSmithKline statement

“We continue to monitor the situation closely, working with the CDC, and will continue to take any and all necessary precautionary steps as directed by CDC.”

- American Airlines spokeswoman Michelle Mohr

“We are undertaking a very aggressive cleaning and sanitizing initiative prior to guests boarding for the next voyage.”

- Carnival Cruise Lines statement

“You still need to start to factor in what that fear quotient could do.”

- Honeywell CEO David Cote

“The gravity of the impact of the Ebola outbreak and Amgen’s expertise in developing monoclonal antibodies provide a unique opportunity to assist in the efforts to manage this growing healthcare concern.”

- Amgen spokeswoman Kristen Davis

“We monitor it on a daily basis and we have not seen any changes in the booking trends.”

- Delta CEO Richard Anderson

“There’s been absolutely no impact on bookings, other than to the cities directly involved.”

- Willie Walsh,  CEO of the International Airlines Group, which includes British Airways and Iberia

“At this stage, Air France is maintaining its flight schedule to and from Guinea (Conakry) and Sierra Leone (Freetown).”

- Company statement

“There are indications that demand in the east is coming off a little bit because of the perception that Ebola is Africa-wide.”

- Emirates president Tim Clark 

“I would hope that we can contribute to resolving or contributing to helping in a global healthcare crisis that we are experiencing to date.”

- Roland Diggelmann, chief operating officer of Roche Diagnostics

“Cepheid, with its prior bio-threat experience, is well positioned.”

- John Bishop, CEO of Cepheid

“We’re hopeful of being able to help but it’s still early days.”

- Sharon McHale, spokeswoman for CSL Limited, an Australian maker of blood products

“The customer who tested positive for Ebola showed no symptoms or signs of illness while on flight.”

- Frontier Airlines tweet

“The research shows that it exhibits anti-Ebola virus activity in horizontal infection experiments on cells and animals.”

- Statement by China’s Sihuan Pharmaceutical, discussing its drug JK-05.

September

“In the case where a user is wearing a lab coat or gown, the under glove should be worn under the cuff of the gown and the over glove should be worn over the cuff.”

- Ansell Limited, Australian-based supplier of protective gloves, statement

“The vaccine to be used by NewLink Genetics was developed originally in Canada and has been studied extensively in non-human primates with very encouraging results.”

- Company statement

August

“The available supply of ZMapp has been exhausted.”

- Mapp Biopharmaceutical statement

“This current outbreak underscores the critical need for effective therapeutic agents to treat the Ebola virus.”

- Mark Murray, Ph.D., CEO of Tekmira

Here’s what companies are saying about Ebola